Hooray!
https://www.sciencedaily.com/releases/2025/10/251029002855.htm
But the takeaway in this article is this:
> Because developing new antibiotics is costly and offers limited financial reward, few pharmaceutical companies are investing in this critical area.
#Health #Science
Yohan Yukiya Sese Cuneta 사요한🦣
npub1hw…zgy26
2025-11-16 20:46:14 GMT
Author Public Key
npub1hwqe4g8p3s5s5yv949u83jt04472yxwn8tq62tj7rk5mz0dsa9kqczgy26Seen on
wss://relay.momostr.pinkPublished at
2025-11-16 20:46:14 GMTEvent JSON
{
"id": "f00f3ddee0f643c0e04ee1b0a70f959ccd2d6b5555b4327f40c4c3c6b866eda8",
"pubkey": "bb819aa0e18c290a1185a97878c96fad7ca219d33ac1a52e5e1da9b13db0e96c",
"created_at": 1763325974,
"kind": 1,
"tags": [
[
"t",
"health"
],
[
"t",
"science"
],
[
"proxy",
"https://c.im/@youronlyone/115561331059164210",
"web"
],
[
"proxy",
"https://c.im/users/youronlyone/statuses/115561331059164210",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://c.im/users/youronlyone/statuses/115561331059164210",
"pink.momostr"
],
[
"-"
]
],
"content": "Hooray!\n\nhttps://www.sciencedaily.com/releases/2025/10/251029002855.htm\n\nBut the takeaway in this article is this:\n\n\u003e Because developing new antibiotics is costly and offers limited financial reward, few pharmaceutical companies are investing in this critical area.\n\n#Health #Science",
"sig": "d823627024502b1d9014481669f81291ea8101729e7c8e74962270ccb3706ca7902d4c3c515312b99cbdc9fa5442058fc41c53d43741b16e917a85bd4aca4a4c"
}